Notes
UK PReventiOn of Myocardial Infarction and Stroke Evaluation (UK-PROMISE) model
2012/2013 British pounds
Reference
Ferket BS, et al. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease. Heart : 11 Jan 2017. Available from: URL: http://doi.org/10.1136/heartjnl-2016-310529
Rights and permissions
About this article
Cite this article
Polypill cost effective for preventing CVD if price reduced. PharmacoEcon Outcomes News 770, 21 (2017). https://doi.org/10.1007/s40274-017-3696-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3696-2